Publications by authors named "Gernot Wolfram"

Claim this Profile
S
Safety and tolerability of ALO-02 (oxycodone hydrochloride and sequestered naltrexone hydrochloride) extended-release capsules in older patients: a pooled analysis of two clinical trials.
Jacquelyn G Wilson, Almasa Bass, Glenn C Pixton, Gernot Wolfram, Richard L Rauck

Curr Med Res Opin· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of naltrexone exposure observed in two phase three studies with ALO-02, an extended-release oxycodone surrounding sequestered naltrexone.
Joseph S Gimbel, Richard L Rauck, Almasa Bass, Jacquelyn Wilson, Glenn Pixton, Gernot Wolfram

J Opioid Manag· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of intravenous oxycodone alone or in combination with naltrexone on measures of respiratory depression: a randomized placebo-controlled study.
Almasa Bass, Lynn R Webster, Kyle T Matschke, Bimal K Malhotra, Gernot Wolfram

Ther Adv Drug Saf· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain.
Arnold J Weil, Elizabeth T Masters, Alexandra I Barsdorf, Almasa Bass, Glenn Pixton, Gernot Wolfram

Health Qual Life Outcomes· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recreational Opioid Users.
Beatrice Setnik, Almasa Bass, Candace Bramson, Naama Levy-Cooperman, Bimal Malhotra, Gernot Wolfram

Pain Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid users.
Miroslav Backonja, Lynn R Webster, Beatrice Setnik, Almasa Bass, Kenneth W Sommerville, Gernot Wolfram

Am J Drug Alcohol Abuse· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational opioid users.
Beatrice Setnik, Candace Bramson, Almasa Bass, Naama Levy-Cooperman, Bimal Malhotra, Gernot Wolfram

J Clin Pharmacol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tanezumab in the treatment of pain from bone metastases.
Maciej Sopata, Nathaniel Katz, William Carey, Michael D Smith, David Keller, Gernot Wolfram

Pain· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment.
Richard L Rauck, Martin E Hale, Almasa Bass, Candace Bramson, Glenn Pixton, Gernot Wolfram

Pain· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee: response.
Egilius L H Spierings, James Fidelholtz, Gernot Wolfram, Michael D Smith, Mark T Brown

Pain· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
Andra Rodica Balanescu, Eugen Feist, Gernot Wolfram, Isabelle Davignon, Michael D Smith

Ann Rheum Dis· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee.
Egilius L H Spierings, James Fidelholtz, Gernot Wolfram, Michael D Smith, Mark T Brown

Pain· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain.
Philippe Poulain, Willy Denier, Joep Douma, Klaus Hoerauf, Mirko Samija, Gernot Wolfram

J Pain Symptom Manage· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis